MED Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Medifast Inc (MED) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock exhibits weak financial performance, bearish technical indicators, and lacks positive catalysts or strong trading sentiment. Additionally, there are no proprietary trading signals or significant insider or hedge fund activity to support a buy decision.
The technical indicators for MED are bearish. The MACD is negative and expanding downward (-0.0659), the RSI is neutral at 34.438, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 10.766), with resistance levels at R1: 11.713 and R2: 12.006.
NULL. There are no recent news, significant insider or hedge fund activity, or proprietary trading signals to act as positive catalysts.
Additionally, the gross margin dropped by -7.79% YoY. The technical indicators are bearish, and there are no recent positive developments in news or trading sentiment.
In Q3 2025, Medifast's revenue dropped to $89.41M (-36.21% YoY), net income fell to -$2.26M (-300.27% YoY), and EPS declined to -$0.21 (-310.00% YoY). Gross margin also decreased to 69.52% (-7.79% YoY), reflecting a significant decline in the company's financial health.
No recent analyst ratings or price target changes are available for MED.
